Full Vaccine Approvals Seen as Boon for Post-Pandemic Protection

U.S. availability of two fully approved Covid-19 shots sets the stage for normalizing vaccination post-pandemic and could beef up incentives for remaining holdouts, health policy professionals say.

Moderna Inc.‘s Spikevax joins the ranks of Pfizer Inc. and BioNTech’s Comirnaty as the second Covid-19 vaccine approved by the FDA and recommended by the Centers for Disease Control and Prevention. Lingering vaccine hesitancy means the country won’t see an immediate uptick in inoculation rates, but the government’s latest action could still ease distribution challenges, encourage more employers to offer boosters, and eventually sway Americans who are leery to get the shot. ...